StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.13+0.05 (+1.62%)

Close on Nov 18, 2026Market cap $178.44MP/E –Yield –

Whitehawk Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Whitehawk Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.4× to 3.3×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×+0.3
2025Dec 31, 20250.7×−0.4
2024Dec 31, 20241.1×+0.7
2023Dec 29, 20230.4×−1.4
2022Dec 30, 20221.9×−1.5
2021Dec 31, 20213.3×+2.8
2020Jan 31, 20200.6×+0.0
2019Dec 31, 20190.5×−0.4
2018Dec 31, 20180.9×−4.0
2017Dec 29, 20174.9×–

More Whitehawk Therapeutics figures

See a number that looks wrong?